Islamabad, Pakistan : The ongoing conflict between Iran and the United States is now creating economic and supply-related problems in several countries across the world. While some nations are dealing with fuel and gas shortages, others are facing disruptions in essential goods and services.
Pakistan has now reportedly started experiencing a medical supply crisis linked to the situation, with shortages of medicines being reported in multiple cities.
Supply Chain Disruptions Hit Pakistan’s Pharma Sector
According to a report by The Express Tribune, the war-like situation has heavily disturbed global supply chains. Shipping expenses have increased significantly, affecting the import of pharmaceutical raw materials used by Pakistan’s medicine industry.
Pakistan depends largely on imported raw materials and finished medicines, and much of this supply was coming through routes now impacted by the conflict. As costs rise and imports slow down, the pharmaceutical sector is facing serious pressure.
Shortage and Price Hike Reported in Major Cities
Reports suggest that cities including Karachi, Lahore, and Islamabad are witnessing shortages of important medicines along with sharp price increases.
The situation is making medical treatment difficult for ordinary citizens, especially for patients suffering from chronic illnesses such as diabetes, heart disease, and cancer. Many families are reportedly struggling to afford essential medicines.
Medicine Prices Have Been Rising Since 2023
The report also highlights that medicine prices in Pakistan have been increasing continuously since 2023. In 2024, prices of several essential medicines reportedly rose by nearly 50 percent.
Another increase followed in 2025, with prices climbing by around 30 to 40 percent again, adding more burden on the public.
GST Decision Added More Pressure
Apart from global supply problems, the decision of the Shehbaz Sharif government to impose 18 percent GST on raw materials and items used in medicine manufacturing has also contributed to higher treatment costs.
Due to rising expenses in production and imports, many essential medicines are becoming increasingly difficult for common people to purchase.
Healthcare Concerns Continue to Grow
With import costs rising, supply chains under pressure, and medicine prices continuing to increase, concerns are growing over the healthcare situation in Pakistan. Experts believe that if disruptions continue for a longer period, the country’s pharmaceutical sector may face even bigger challenges in the coming months.